Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years

Authors:

Abstract
Key Points: GRFS is similar between older and younger patients using FCC conditioning but comorbidities impact on outcome of SAA HSCT. Immunomodulatory B lymphocytes potentially contribute to control of alloreactivity and low GVHD after FCC HSCT.

This publication has 47 references indexed in Scilit: